Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In April 2021, the FDA approved the 100th monoclonal ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...

Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. Antibody-drug conjugates (ADCs) are promisingly emerging cancer therapies that ...

For therapies based on monoclonal antibodies (mAbs), bioprocessors continually search for ways to improve the development process. Machine learning (ML) offers one useful tool. As Mariano Nicolas Cruz ...

Antibodies play a vital role in the immune system by providing protection against foreign invaders, such as bacteria and viruses. Produced by B cells, antibodies are protein molecules that can be ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Austin, Texas, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Antibody Discovery Market Size & Growth Analysis: According to SNS Insider, the Antibody Discovery Market size was valued at USD 8.42 billion in 2024 ...

Instil Bio said its subsidiary has discontinued clinical development of AXN-2510 and terminated its collaboration agreement with ImmuneOnco Biopharmaceuticals (Shanghai) for AXN-2510 and AXN-27M.